Technical Analysis for CPIX - Cumberland Pharmaceuticals Inc.

Grade Last Price % Change Price Change
D 1.87 3.89% 0.07
CPIX closed up 3.89 percent on Monday, March 18, 2024, on 63 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish 3.89%
Lower Bollinger Band Walk Weakness 3.89%
Oversold Stochastic Weakness 3.89%
Fell Below 200 DMA Bearish 3.89%
Lower Bollinger Band Walk Weakness 3.89%
Below Lower BB Weakness 3.89%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 16 hours ago
Rose Above Previous Day's High about 17 hours ago
Up 5% about 17 hours ago
Up 1 ATR about 17 hours ago
Gap Up Partially Closed about 18 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cumberland Pharmaceuticals Inc. Description

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Drugs Pain Clinical Development Medication Gastroenterology Analgesics Constipation Fever Hepatotoxins Paracetamol Prescription Product Prescription Products Hepatorenal Syndrome Treatment Of Hepatorenal Syndrome

Is CPIX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.3587
52 Week Low 1.43
Average Volume 12,057
200-Day Moving Average 1.81
50-Day Moving Average 2.03
20-Day Moving Average 2.03
10-Day Moving Average 1.92
Average True Range 0.12
RSI (14) 42.53
ADX 24.01
+DI 13.73
-DI 26.32
Chandelier Exit (Long, 3 ATRs) 1.87
Chandelier Exit (Short, 3 ATRs) 2.17
Upper Bollinger Bands 2.31
Lower Bollinger Band 1.75
Percent B (%b) 0.21
BandWidth 27.40
MACD Line -0.06
MACD Signal Line -0.02
MACD Histogram -0.0325
Fundamentals Value
Market Cap 27.87 Million
Num Shares 14.9 Million
EPS -0.17
Price-to-Earnings (P/E) Ratio -11.00
Price-to-Sales 0.80
Price-to-Book 0.88
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.01
Resistance 3 (R3) 2.02 1.98 1.99
Resistance 2 (R2) 1.98 1.94 1.98 1.98
Resistance 1 (R1) 1.93 1.92 1.95 1.92 1.97
Pivot Point 1.89 1.89 1.90 1.88 1.89
Support 1 (S1) 1.83 1.85 1.86 1.82 1.77
Support 2 (S2) 1.79 1.83 1.79 1.76
Support 3 (S3) 1.74 1.79 1.75
Support 4 (S4) 1.73